uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted August 5, 2016

U.S. Marshals Seize $150,00 Worth of Kratom

On August 4, 2016, the FDA announced that U.S. Marshals seized approximately $150,000 worth of dietary supplements labeled as containing kratom from Nature Therapeutics (dba Kratum Therapy). The action was taken at the request of the FDA.

Kratom (Mitragyna speciosa), also called mitragynine extract, biak-biak, cratom, gratom, ithang, kakuam, katawn, kedemba, ketum, krathom, krton, mambog, madat, Maeng da leaf, nauclea, Nauclea speciosa, or thang is a tree native to Southeast Asia. Supplements containing kratom typically contain powdered leaves or extract sold in powder, capsules or liquid, and are promoted for pain relief or energy.

Kratom has pharmacological effects similar to morphine and other opiates. Consumption has been associated with respiratory depression, nervousness, agitation, aggression, sleeplessness, hallucinations, delusions, tremors, loss of libido, constipation, skin hyperpigmentation, nausea, vomiting, and severe withdrawal symptoms.

"The FDA will continue to take aggressive enforcement action to safeguard the public from harmful drug products illegally marketed as treatments for which they have not been studied or approved," Melinda Plaisier, the FDA's associate commissioner for regulatory affairs, stated in the FDA press release.

In 2014, the FDA issued an import alert in 2014 on all products containing kratom.

See Related Warnings:

Over $400,000 Worth of Kratom Supplements Seized by U.S. Marshals

U.S. Marshals Seize $5 Million Worth of Kratom

Products Containing Kratom Recalled Following FDA Import Alert

$2 Million In Weight Loss and "Fat-Burning" Supplements Seized

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

FDA Requests Seizure of More Supplements Containing Ephedrine Alkaloids

To read the FDA's press release, use the link below.